Related by context. All words. (Click for frequent words.) 69 CMV infection 69 acute GvHD 69 CMV infections 68 metastatic neuroendocrine tumors 67 thrombotic complications 66 CMV disease 66 cytomegalovirus infection 66 post surgical adhesions 66 S. aureus infection 65 Hepatocellular Carcinoma HCC 65 hepatorenal syndrome 65 corticosteroid therapy 65 cerebral vasospasm 65 Gleevec resistant 65 antimicrobial prophylaxis 65 haematologic 65 Catheter Associated 64 humoral responses 64 invasive aspergillosis 64 ATIR 64 anagrelide 64 allograft rejection 64 invasive candidiasis 64 CMV seropositive 64 FluCAM arm 64 Candida infection 64 antibody mediated 64 Contrast Induced Nephropathy CIN 64 Cimzia TM 63 haematopoietic 63 chronic GVHD 63 steroid refractory 63 postoperative AF 63 ImmuKnow 63 metastatic malignant 63 Vacc 4x 63 allogeneic bone marrow 63 radioiodine therapy 63 vWD 63 vidofludimus 63 recurrent glioma 63 riociguat 63 liver resection 63 intracranial hemorrhage ICH 63 rFVIIa 63 allogeneic hematopoietic stem cell 63 bacterial colonization 63 CIMZIA ™ 63 immunosuppressed patients 63 pericardial effusion 63 hemorrhagic cystitis 63 Adhibit 63 gastrointestinal stromal tumors GIST 62 Liver transplantation 62 Unstable angina 62 bronchogenic carcinoma 62 percutaneous drainage 62 r hGH 62 intravascular hemolysis 62 myeloid metaplasia 62 INVEGA ® 62 urothelial cancer 62 EXJADE 62 either acutely decompensated 62 HER2 overexpression 62 PROCHYMAL 62 NeuroStar TMS Therapy 62 rebleeding 62 dissolving blood clots 62 CIMZIA TM certolizumab pegol 62 hypereosinophilic syndrome 62 postoperative pulmonary 62 Natalizumab 62 clevidipine 62 hemorrhagic complications 62 prolonged QT interval 62 tumor lysis syndrome 62 HbF 62 thromboembolic disease 62 prospective multicenter study 62 herpes zoster shingles 62 parasitemia 62 metastatic malignant melanoma 62 neovascularisation 62 VTE prophylaxis 62 refractory angina 62 recurrent glioblastoma multiforme 62 bowel resection 62 coagulation abnormalities 62 transfusion syndrome 62 nephrotoxicity 62 upper gastrointestinal bleeding 62 postoperative infections 62 RSV infection 62 ofpatients 62 CTAP# Capsules 62 canakinumab 62 transgene expression 62 hepatitis C viral infection 62 Host Disease GvHD 62 Pseudomonas aeruginosa infections 62 platelet reactivity 62 vWF 62 immunopathology 62 hepatitis C HCV 62 autologous SCT 62 CRBSIs 62 colorectal liver metastases 61 intraoperative complications 61 intracoronary 61 polycythemia vera essential thrombocythemia 61 Poly ICLC 61 graft occlusion 61 renal toxicity 61 malignant ascites 61 gastric carcinoma 61 FVIIa 61 cardiac dysfunction 61 GISTs 61 Hypotension 61 virologic responses 61 Hydroxyurea 61 necrotizing enterocolitis NEC 61 allogenic 61 immunocompetent 61 Aspergillus infections 61 fulminant hepatic failure 61 ANCA associated 61 FVIII inhibitors 61 chlamydial 61 fallopian tube cancers 61 candidemia 61 HepaGam B TM 61 catheter occlusion 61 ImmuKnow R 61 HBeAg positive patients 61 Twinrix 61 ischemic mitral regurgitation 61 tamponade 61 type 1diabetes 61 postoperative ileus 61 variceal bleeding 61 GIST tumors 61 imatinib resistance 61 allogeneic HSCT 61 cellular immunotherapy 61 eTag assays 61 sacral nerve stimulation 61 nucleotide analog 61 transplantation HCT 61 Vascugel ® 61 lymphoid organs 61 cranial irradiation 61 squamous cell lung cancer 61 Staphylococcus aureus infections 61 Mitomycin C 61 rhinovirus infection 61 kidney urologic 61 post thrombotic syndrome 61 neutropaenia 61 antiplatelet medications 61 TNF antagonist 61 myocardial reperfusion 61 stratifying patients 61 CIMZIA TM 61 pulmonary artery banding 61 hematological parameters 61 diabetes mellitus DM 61 interferon ribavirin 61 tracheal intubation 61 Interferon beta 61 edifoligide 61 Hepatitis C virus HCV 61 cytotoxic effects 61 tissue oxygenation 61 infective endocarditis 61 hepatic toxicity 61 lupus nephritis 61 postoperative atrial fibrillation 61 postoperative morbidity 61 HeFH 61 Microplasmin 61 Cardiotoxicity 61 Aethlon Hemopurifier ® 61 curative therapy 61 nosocomial infection 61 urothelial carcinoma 61 HSCT 61 tumor histology 61 renal scarring 61 hypervascular tumors 61 relapsed MM 61 immunosuppressive regimens 61 Lymphocytic 61 GvHD 61 systemic fungal infections 61 chemotherapy induced neutropenia 61 reactogenicity 61 MAGE A3 ASCI 61 enterococcal 61 colorectal carcinoma 61 antiphospholipid syndrome 61 antiplatelet therapies 61 erythropoietic 61 perioperative complications 61 heparin induced thrombocytopenia 60 myelomas 60 MyVax ® 60 recurrent bladder 60 nosocomial pneumonia 60 cobiprostone 60 Intravenous immunoglobulin 60 VP# [004] 60 vasogenic edema 60 CD4 + T lymphocytes 60 atherothrombotic 60 subcutaneous immunoglobulin 60 cytopenia 60 antithrombotic therapy 60 Xanafide 60 hyperacute 60 VZV 60 systemic toxicity 60 intravenous cyclophosphamide 60 cytomegalovirus CMV 60 ADPKD 60 retransplantation 60 hA# 60 MGd 60 immunomodulatory therapy 60 Hemopurifier 60 tardive dyskinesia TD 60 lung resection 60 trophoblast cells 60 efalizumab 60 NOD SCID mice 60 rindopepimut 60 calcineurin inhibitor 60 oral anticoagulant therapy 60 Acute Myeloid Leukaemia AML 60 severe oral mucositis 60 varicella infection 60 immuno compromised patients 60 cervical lymph nodes 60 Immunosuppressive drugs 60 octreotide LAR 60 HepaGam B 60 tumor metastases 60 severe neutropenia 60 aneurysm rupture 60 related bloodstream infections 60 stem cell engraftment 60 neuroblastoma tumors 60 BEXXAR Therapeutic Regimen 60 Catheter ablation 60 transplantation HSCT 60 deep venous thromboses 60 tigecycline 60 smoldering myeloma 60 complement inhibitor eculizumab 60 mycophenolate mofetil 60 humoral immunity 60 neurologic complications 60 FXIII 60 pancreatic adenocarcinoma 60 choriocarcinoma 60 CIPN 60 Adult Stem Cell Therapy 60 replicon 60 unruptured aneurysm 60 HBV vaccine 60 myocardial revascularization 60 lung fibrosis 60 ano genital warts 60 transplanted islets 60 bacterial sepsis 60 localized prostate 60 plasma kallikrein 60 perioperatively 60 Vidaza azacitidine 60 #beta estradiol 60 immune reconstitution 60 varices 60 S. aureus infections 60 mycophenolate mofetil MMF 60 Carotid endarterectomy 60 anastomotic leak 60 ICD shocks 60 p# biomarker 60 ZOSTAVAX 60 metastatic uveal melanoma 60 epoetin alpha 60 neuroendocrine cancers 60 JAK2 enzyme 60 Ribavirin causes 60 primary hyperparathyroidism 60 portal vein thrombosis 60 Altastaph 60 K ras mutations 60 idiopathic thrombocytopenic purpura ITP 60 NAbs 60 carotid artery stenosis 60 TriGrid ™ 60 invasive fungal infections 60 Telintra 60 treat benign prostatic 60 thrombolytics 60 investigational monoclonal antibody 60 SSc 60 unresectable tumors 60 Warfarin Coumadin 60 immune modulator 60 delayed CINV 60 AGILECT R 60 MYCAMINE 60 Kepivance 60 venous blood clots 60 myelofibrosis polycythemia vera 60 vesicoureteral reflux 60 Idiopathic Thrombocytopenic Purpura ITP 60 diabetic kidney 60 Allogeneic 60 graft dysfunction 60 dose escalation phase 60 S. aureus isolates 60 ximelagatran 60 Hepatitis B virus HBV 60 sarcomatoid 60 overactive bladder syndrome 60 recurrent glioblastoma multiforme GBM 60 GVHD 60 Guillain Barre Syndrome GBS 60 biventricular pacing 60 BrachySil TM 60 immunosuppression therapy 60 icatibant 60 pre operatively 60 tolevamer 60 immune globulins 60 pretransplant 60 N. gonorrhoeae 60 CINTREDEKIN BESUDOTOX 60 renal allograft 60 SCIg 60 sonographic diagnosis 60 Acute Ischemic Stroke 60 precancerous cervical lesions 60 busulfan 60 LVNC 60 STARFlex ® 60 transarterial 60 endometrial hyperplasia 60 thymectomy 60 ImmuKnow assay 60 cytoreduction 60 QuadraSphere 60 vasospasm 60 histological subtype 60 Glypromate 60 cisplatin chemotherapy 60 Acute Radiation Syndrome ARS 60 follicular lymphomas 60 venous thromboembolic disease 60 HepaMate 60 Tumor Response 60 postoperative mortality 60 Inhaled nitric oxide 60 Cardiopulmonary bypass 60 hypoperfusion 60 psoriatic arthritis PsA 60 Spectranetics laser 60 Severe Sepsis 60 nutlin 3a 60 donor nephrectomy 60 virological response 60 Human cl 60 leukocyte count 60 torsade de pointes 59 velafermin 59 ara C 59 TMS Therapy 59 induce remission 59 GPIIb IIIa 59 DVT PE 59 biliary tract cancer 59 uterine fibroid 59 CoreValve System 59 Sertoli cells 59 rt PA 59 tumor necrosis 59 thromboembolic complications 59 RAS mutations 59 IgM antibodies 59 hemodynamically stable 59 postoperative infection 59 elective PCI 59 JAK2 inhibitor 59 CYT# potent vascular disrupting 59 von Willebrand factor 59 leukaemic stem cells 59 Islet transplantation 59 acute myocardial ischemia 59 Ileus 59 VA# [002] 59 Acute Myocardial Infarction AMI 59 cilengitide 59 rhinovirus infections 59 myocardial tissue 59 MYDICAR 59 pretreatment serum 59 PTLD 59 virologic breakthrough 59 Virulizin ® 59 ICD implantation 59 HIV HCV coinfected 59 HBV replication 59 Lung transplantation 59 dysplastic lesions 59 anti coagulant therapy 59 Pharmacokinetics PK 59 Rilonacept 59 immune thrombocytopenic purpura ITP 59 Resten NG 59 synthetic retinoid 59 Corgentin 59 systemic amyloidosis 59 treatment naive genotype 59 MALT lymphoma 59 NAVISTAR R 59 corticosteroid dose 59 anterior uveitis 59 Acute Decompensated Heart Failure 59 EGFR receptor 59 lichen planus 59 nonpharmacologic 59 Chronic lymphocytic leukemia 59 Surgical resection 59 DAPT 59 samalizumab 59 systemic immunosuppressive drugs 59 Alferon N 59 T1DM 59 CMV vaccine 59 GW# [003] 59 warfarin dosage 59 immunosuppressive regimen 59 physiological abnormalities 59 mRCC 59 metastatic bladder 59 MGuard ™ 59 diphtheria pertussis whooping cough 59 hemodilution 59 CD# upregulation 59 cardiopulmonary bypass surgery 59 mechanically ventilated patients 59 Lisofylline 59 treat dysmenorrhea 59 mepolizumab 59 CRBSI 59 gastric adenocarcinoma 59 histologic subtype 59 DEB# 59 Degarelix 59 Varicella zoster virus 59 bolus dose 59 HIB vaccine 59 acute aortic dissection 59 adverse cytogenetics 59 thyroid carcinoma 59 pretargeting 59 GAMMAGARD 59 hemodynamic instability 59 edifoligide E2F Decoy 59 antiangiogenic drugs 59 primidone 59 TUMT 59 daptomycin 59 bacterium Neisseria meningitidis 59 bifurcation stent 59 Ebstein anomaly 59 polycythemia vera PV 59 hematologic toxicity 59 inhibitor RG# 59 tuberous sclerosis TS 59 HBsAg 59 combination antiretroviral therapy 59 osteoporotic vertebral compression fractures 59 DEFLUX 59 porcine derived 59 aortic valve stenosis 59 postoperative complication 59 Fully Covered Stent 59 Tasigna prolongs 59 membranous nephropathy 59 Legg Calvé Perthes disease 59 staphylococcal infections 59 plasma pharmacokinetics 59 FASLODEX 59 sirolimus eluting stents 59 TransVax 59 KETEK 59 hematopoietic malignancies 59 intradermal injections 59 hemodynamic measurements 59 leukemia ALL 59 WT1 59 bovine thrombin 59 IVIG therapy 59 trivalent influenza vaccine 59 NMIBC 59 rotavirus diarrhea 59 myeloperoxidase 59 Delayed Graft Function 59 epithelial tumors 59 Latent TB 59 tumoral 59 recurrent malignant glioma 59 Transplant Rejection 59 grade glioma 59 prevent reinfection 59 hematologic disorders 59 diagnostic biomarker 59 ReN# 59 thromboembolic 59 pancreatic islet 59 balloon valvuloplasty 59 Lupus nephritis 59 refractory gout 59 AV fistulas 59 methicillin susceptible Staphylococcus aureus 59 Thrombocytopenia 59 recombinant erythropoietin 59 gamma globin gene 59 Toxicities 59 atrial arrhythmias 59 ZOLINZA 59 G6PD deficiency 59 Kinoid 59 ChronVac C R 59 lumbar spinal stenosis LSS 59 Golimumab 59 tissue perfusion 59 Vasogen Celacade 59 thrombocytopenic 59 transcatheter closure 59 pulmonary toxicity 59 autoimmune reactions 59 ALI ARDS 59 Nilotinib 59 artery stenosis 59 NATRECOR ® 59 von Willebrand 59 Eculizumab 59 tumorigenicity 59 Noxafil 59 elacytarabine 59 Revascor TM 59 WNV encephalitis 59 recurrent genital herpes 59 cervical carcinoma 59 Acute Renal Failure 59 lung metastasis 59 ancrod 59 non metastatic osteosarcoma 59 intracerebral 59 herpes zoster vaccine 59 APTIVUS r 59 Certolizumab pegol 59 achieved CCyR 59 solid organ transplantation 59 EGFR HER2 59 angiographically 59 NNRTI resistant virus 59 genital herpes infections 59 AGHD 59 venous stasis ulcers 59 kidney allograft 59 external genital lesions 59 diabetic retinopathy DR 59 hemodialysis patients 59 biologic DMARD 59 pelvic malignancies 59 serum antibody 59 atrial tachyarrhythmias 59 Diabetic Neuropathy 59 allogeneic stem cell 59 HBV infection 59 Hemopurifier ® 59 hematopoietic cell 59 hepatitis B infection 59 immune reconstitution syndrome 59 Leukemias 59 pT3 59 recurrent glioblastoma 59 latent tuberculosis TB 59 response CCyR 59 CMV retinitis 59 everolimus eluting stents 59 pyridostigmine 59 pneumococcal pneumonia 59 cystic fibrosis chronic pancreatitis 59 Dacogen decitabine 59 rituximab Rituxan 59 gastrointestinal GI motility disorders 59 disease GVHD 59 prostate adenocarcinoma 59 functional mitral regurgitation 59 lymphocytosis 59 chorioamnionitis 59 Traficet EN 59 NPM1 mutation 59 neonatal morbidity 59 IOP lowering 59 VAPRISOL 59 motor neuron degeneration 59 neoplastic diseases 59 Venous thromboembolism 59 deferiprone 59 MCyR 59 adult mesenchymal stem 59 Dasatinib 59 abnormal uterine bleeding 59 protein tyrosine phosphatase 59 Known hypersensitivity 59 intradermal injection 59 MVA MUC1 IL2 59 STRIDE PD 59 leukemic 59 biventricular failure 59 TAXUS Liberté stent 59 coronary revascularization procedures 59 IL 1ß 59 anti CD3 antibody 59 hyperphenylalaninemia HPA due 59 hyperoxaluria 59 infarcted myocardium 59 MitraClip device 58 Epstein Barr Virus EBV 58 C1 INH 58 AA Amyloidosis 58 intimal hyperplasia 58 myelomeningocele 58 associated pneumonia VAP 58 immunological responses 58 intra articular injection 58 locoregional 58 pulmonary dysfunction 58 Coronary artery bypass 58 mitral regurgitation MR 58 viral reactivation 58 liver grafts 58 relapsing remitting MS RRMS 58 sJIA 58 erythema nodosum 58 esophagogastric 58 allogeneic hematopoietic cell 58 thrombotic thrombocytopenic purpura TTP 58 PPCM 58 potent cytotoxic 58 Severe Primary IGFD 58 leukoencephalopathy 58 polyomavirus nephropathy 58 COPD exacerbations 58 OHR/AVR# 58 Leydig cell 58 noninfectious uveitis 58 colorectal adenoma 58 idiopathic myelofibrosis 58 ESBLs 58 teriflunomide 58 fibrin deposition 58 metaplasia 58 urologic diseases 58 LEUKINE 58 pheochromocytoma 58 oral rivaroxaban 58 Tasimelteon 58 symptomatic paroxysmal AF 58 fluoroquinolone resistance 58 PROMACTA 58 NV1FGF 58 TAXUS Express Stent 58 prostate carcinoma 58 enterotoxigenic E. coli 58 Sezary syndrome 58 Diabetic neuropathy 58 acadesine 58 FFR measurements 58 postoperative delirium 58 leukotriene receptor antagonist 58 SNT-MC#/idebenone 58 P. falciparum malaria 58 Non Alcoholic Fatty 58 thrombocytosis 58 symptomatic intracranial hemorrhage 58 glycated hemoglobin levels 58 cardioverter defibrillator 58 bioartificial liver 58 AFRS TM 58 HBV infections 58 uPA 58 conjugate vaccines 58 bacterial prostatitis 58 surrogate endpoint 58 posttransplant 58 peritumoral brain edema 58 BENICAR HCT 58 BCG refractory 58 unstable angina pectoris 58 Scheuermann kyphosis 58 medically refractory 58 biliary obstruction 58 fibrotic disease 58 PLX cells 58 post transplant lymphoproliferative 58 pancreatectomy 58 endoscopic resection 58 adult chronic ITP 58 docetaxel Taxotere ® 58 Renal Cell Carcinoma RCC 58 causative pathogen 58 thrombus formation 58 Radiofrequency ablation 58 LEAPS H#N# 58 varicella zoster virus VZV 58 mismatched bone marrow 58 HBeAg negative 58 induces antibodies 58 Clostridium difficile infections 58 TransVax tm 58 paralytic poliomyelitis 58 virologic 58 morphometric vertebral fractures 58 OrCel 58 corifollitropin alfa 58 including eniluracil ADH 58 Critical Limb Ischemia CLI 58 vaso occlusive crisis 58 basiliximab 58 bronchopulmonary dysplasia BPD 58 histologies 58 ACZ# 58 chronic eosinophilic leukemia 58 Vascugel 58 BioSTAR R 58 chronic thromboembolic pulmonary 58 pancreatic carcinoma 58 hyperprolactinemia 58 intravesical instillation 58 C. difficile toxins 58 palliative radiotherapy 58 mediastinitis 58 immunosuppressives 58 lesional 58 Naive Patients 58 operable breast cancer 58 cranial radiation 58 vertebral compression fractures 58 urethral stricture 58 Aethlon Hemopurifier R 58 haemodynamic 58 endotoxemia 58 TroVax ® 58 CD8 responses 58 ovarian hyperstimulation syndrome OHSS 58 vascular insufficiency 58 saphenous vein grafts 58 choroidal neovascularization 58 prostate cancer CaP 58 Eisenmenger syndrome 58 skeletal metastases 58 postoperative bleeding 58 multivalent vaccine 58 somatostatin analogues 58 coagulation disorders 58 Decitabine 58 eczema vaccinatum 58 EGFR TKI 58 MYLOTARG 58 orchitis 58 pDC 58 Meningiomas 58 retroviral vectors 58 SIMPONI TM 58 corneal ectasia 58 nucleotide analogue 58 cisplatin resistant 58 rotavirus gastroenteritis 58 renovascular hypertension 58 Vidaza ® 58 arterial calcification 58 Phase #b/#a clinical 58 precancerous condition 58 Sym# 58 autologous bone marrow 58 percutaneous intervention 58 thoracoscopic lobectomy 58 prognostic indicator 58 HuMax EGFr 58 Ivabradine 58 photodynamic treatment 58 lung epithelium 58 rtPA 58 Motavizumab 58 atherosclerotic lesions 58 anti angiogenic agents 58 huN# DM1 58 inotropic 58 contractile muscle 58 lamivudine resistant 58 primary percutaneous coronary 58 intracranial stenosis 58 EBV infection 58 fulvestrant 58 mucinous 58 Dalbavancin 58 symptomatic VTE 58 aortic dissections 58 Postoperative complications 58 BCR ABL mutations 58 neonatal sepsis 58 Enzastaurin 58 Cytotoxic T 58 relapsed ALL 58 ORENCIA R 58 HER2 expression 58 immunosuppressive therapies 58 seminoma 58 SHPT 58 metastatic lung cancer 58 visilizumab 58 angiographic outcomes 58 APTIVUS 58 therapeutic regimens 58 Cleviprex TM clevidipine 58 hepatocellular carcinoma liver 58 QTc prolongation 58 cancerous colon polyps 58 interferon beta therapy 58 urolithiasis 58 cytogenic 58 colorectal metastases 58 esophageal carcinoma 58 autologous transplants 58 secondary efficacy endpoint 58 HALO# [002] 58 thrombolytic agents 58 malignant lymphoma 58 Aptivus ® 58 ispinesib administered 58 reperfusion injury 58 pT2 58 aldosterone antagonists 58 cardiac allograft vasculopathy 58 LV dysfunction 58 Glioblastoma Multiforme 58 basal bolus regimen 58 chemoradiation therapy 58 Hurthle cell 58 PASI scores 58 epiglottitis 58 reslizumab 58 alteplase 58 recurrent venous thromboembolism 58 recurrent VTE 58 probiotic supplementation 58 pharmacokinetic PK profile 58 immunosuppressive agents 58 dyskinetic 58 immunocompetent patients 58 TYZEKA 58 sodium stibogluconate 58 immunologically matched 58 chronic myocardial ischemia 58 DCVax R 58 intracavitary 58 transthyretin TTR mediated amyloidosis 58 complete cytogenetic response 58 hypoxemia 58 lymphoid tumors 58 gastrointestinal stromal tumors GISTs 58 intraventricular 58 cancerdefine 58 HeartNet 58 KRAS status 58 cardiopulmonary bypass CPB 58 SomatoKine 58 OncoVEX GM CSF 58 ischemic complications 58 mutated K ras 58 acute GVHD 58 hypersensitivity allergic reactions 58 NOMID 58 Angioedema 58 adeno associated viruses 58 STARFlex R 58 BoNTA 58 intravenous bisphosphonates 58 CTO recanalization 58 tumor resection 58 glucocorticoid therapy 58 Malignant Glioma 58 cytopenias 58 Azedra 58 DFMO 58 nonischemic 58 dual endothelin receptor antagonist 58 immunosuppression 58 cervical intraepithelial neoplasia 58 shingles herpes zoster 58 colorectal cancer liver metastases 58 immunomodulation 58 liposomal amphotericin B 58 G#DT 58 beta globin gene 58 salmeterol fluticasone 58 essential thrombocythemia ET 58 carcinoid tumors 58 inotropes 58 vascular occlusion 58 voriconazole 58 colorectal adenocarcinoma 58 Cyclosporine 58 ORENCIA ® 58 LNG IUS 58 glomerular filtration 58 Synchrony lens 58 cerebral ischemia 58 antitumor efficacy 58 inflammatory demyelinating 58 antiangiogenic therapy 58 lactate dehydrogenase 58 endocrine pancreas 58 variceal hemorrhage 58 ADEs 58 graft patency 58 commercialize deforolimus 58 Cerashield TM 58 Bendamustine 58 biventricular 58 vProtect TM Luminal Shield 58 Vascugel R 58 Circulating tumor cells 58 Virologic 58 tipranavir ritonavir 58 serogroup B 58 dexanabinol 58 artery embolization 58 mutated KRAS 58 lomitapide 58 anthracycline chemotherapy 58 overt nephropathy 58 NF kB pathway 58 TLIF 58 experimentally induced 58 LCMV infection 58 onabotulinumtoxinA 58 revascularization procedure 58 inhaled nitric oxide 58 perioperative mortality 58 Fingolimod 58 aprepitant 58 Alphanate R 58 decompensated heart failure 58 pulmonary hypertension PH 58 Follicular Lymphoma 58 Epstein Barr virus EBV 58 renal transplantation 58 paracentesis 58 IPAH 58 recombinant tissue plasminogen 58 primary immunodeficiency PI 58 recombinant vector 58 acute lymphoblastic 58 VerifyNow 58 hemolytic 58 RISPERDAL ® 58 Specifid 58 leukemia AML 58 hepatectomy 58 solithromycin 58 pulmonary metastases 58 breast cancer metastasis 58 renal tumors 58 nicardipine 58 Pegylated Interferon 58 CAUTI 58 cell transplantation 58 Streptococcus pneumonia 58 astrocytomas 58 Dacogen injection 58 transfusion transmitted 58 Arteriovenous 58 polymicrobial infections 58 pelvic lymphadenectomy 58 hemolytic disease 58 pegylated IFN 58 immunosuppressant drug 58 PegIFN RBV